Company Overview - Voyager Therapeutics, Inc. is a biotechnology company focused on using genetics to treat neurological diseases [3] - The company's pipeline includes programs targeting Alzheimer's disease, Friedreich's ataxia, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and other central nervous system diseases [3] - Voyager utilizes its TRACER™ AAV capsid discovery platform to create novel capsids for enhanced brain penetration of genetic medicines [3] Recent Events - Alfred W. Sandrock, Jr., M.D., Ph.D., CEO of Voyager, will participate in a pre-recorded fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference [1] - An on-demand webcast of the fireside chat will be available on Voyager's website starting at 7:00 a.m. ET on June 17, 2025, and will be archived for at least 30 days [2]
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference